Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

15

Revenue 2017

Neulasta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Neulasta was produced by Amgen.

Amgen CEO says Aimovig is “one of most successful launches”

Amgen CEO says Aimovig is “one of most successful launches”

Overall, Amgen posted a 2% rise in revenues to $5.78bn in the quarter, despite pressure on older drugs like while blood cell booster Neulasta (pegfilgrastim) which showed the first signs

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals and ERA Consulting’s Udenyca (pegfilgrastim), both alternatives to Amgen’s Neulasta  brand for neutropenia and febrile neutropenia due to chemotherapy.

Novartis doubles down on biosimilars with Biocon alliance

Novartis doubles down on biosimilars with Biocon alliance drug Herceptin (trastuzumab) and Amgen's long-acting white cell booster Neulasta (pegfilgrastim) last August at the request of the EMA.

Biocon backs away from biosimilar filings in Europe

Biocon backs away from biosimilar filings in Europe EMA asks biotech to withdraw Herceptin and Neulasta biosimilar filings. Indian biotech Biocon has said its plan to launch two new biosimilars in Europe has been stymied by issues at its ... Sales of Herceptin were around $7bn last year, while Amgen

Novartis says its biosimilar sales should reach $1bn this year

Novartis says its biosimilar sales should reach $1bn this year The biosimilar is also under review in Europe. Meanwhile, Novartis confirmed that it will have to carry out a new clinical trial on its biosimilar version of Amgen's Neulasta (pegfilgrastim),

1 2 3 4 5 6 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...
International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...

Infographics